BF066, a novel dual target antiplatelet agent without significant bleeding

about

The pyrrolidinoindoline alkaloid Psm2 inhibits platelet aggregation and thrombus formation by affecting PI3K/Akt signaling Structure-activity relationship studies for multitarget antithrombotic drugs.

P2860

Q37254574-7A395832-9970-4E18-9E34-90974E7319E0 Q38795299-A47DDCFD-48CB-41B8-BBB1-E5601B6911A5

P2860

BF066, a novel dual target antiplatelet agent without significant bleeding

Item

http://www.wikidata.org/entity/Q27334889

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

BF066, a novel dual target antiplatelet agent without significant bleeding

@ast

BF066, a novel dual target antiplatelet agent without significant bleeding

@en

BF066, a novel dual target antiplatelet agent without significant bleeding

@nl

type

Item

label

BF066, a novel dual target antiplatelet agent without significant bleeding

@ast

BF066, a novel dual target antiplatelet agent without significant bleeding

@en

BF066, a novel dual target antiplatelet agent without significant bleeding

@nl

prefLabel

BF066, a novel dual target antiplatelet agent without significant bleeding

@ast

BF066, a novel dual target antiplatelet agent without significant bleeding

@en

BF066, a novel dual target antiplatelet agent without significant bleeding

@nl

P1476

BF066, a novel dual target antiplatelet agent without significant bleeding

@en

P2093

ChangE Pan

http://www.w3.org/2001/XMLSchema#string

Guangda Liu

http://www.w3.org/2001/XMLSchema#string

Hongguang Du

http://www.w3.org/2001/XMLSchema#string

Jianqin Ye

http://www.w3.org/2001/XMLSchema#string

Xunbin Wei

http://www.w3.org/2001/XMLSchema#string

Yan Zhang

http://www.w3.org/2001/XMLSchema#string

Zhongren Ding

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-platelet therapy: phosphodiesterase inhibitors.

Role of antiplatelet drugs in the prevention of cardiovascular events

Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro

Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses

RGT, a synthetic peptide corresponding to the integrin beta 3 cytoplasmic C-terminal sequence, selectively inhibits outside-in signaling in human platelets by disrupting the interaction of integrin alpha IIb beta 3 with Src kinase.

The kinetics of αIIbβ3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapy.

Systemic antithrombotic effects of ADAMTS13.

The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation.

A platelet tetraspanin superfamily member, CD151, is required for regulation of thrombus growth and stability in vivo.

A(2A) adenosine receptors in human peripheral blood cells

P304

e40451

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4521450

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0040451

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Si Zhang

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229427751

http://www.w3.org/2001/XMLSchema#string

P698

22815749

http://www.w3.org/2001/XMLSchema#string

P932

3398006

http://www.w3.org/2001/XMLSchema#string

BF066, a novel dual target antiplatelet agent without significant bleeding

about

P2860

P2860

BF066, a novel dual target antiplatelet agent without significant bleeding

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P3181

P356

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P50

P577

P5875

P698

P932